OptimizeRx Corp — Director's Dealing 2023

Apr 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2023-04-18

Reporting Person: FEBBO WILLIAM J (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-18	Restricted Stock Units	$	A	86685	Acquired		Common (86685.0)	Direct
2023-04-18	Stock Option	$14.42	A	161698	Acquired	2028-04-17	Common (161698.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.

F2: The restricted stock units vest in three equal annual installments beginning April 18, 2024, the first anniversary of the grant date.

F3: The stock option vests in three equal annual installments beginning April 18, 2024, the first anniversary of the grant date.